Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03564340
Title Study of REGN4018 Administered Alone or in Combination With Cemiplimab in Patients With Platinum-Resistant Ovarian Cancer
Recruitment Recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Regeneron Pharmaceuticals
Indications

ovary epithelial cancer

fallopian tube cancer

peritoneum cancer

Therapies

Cemiplimab + REGN4018

REGN4018

Age Groups: adult | senior
Covered Countries USA | BEL

Facility Status City State Zip Country Details
University of Alabama at Birmingham Recruiting Birmingham Alabama 35294 United States Details
The General Hospital Corporation d/b/a Massachusetts General Hospital Recruiting Boston Massachusetts 02214 United States Details
Dana Farber Cancer Institute Recruiting Boston Massachusetts 02215 United States Details
Roswell Park Cancer Institute Withdrawn Buffalo New York 14263 United States Details
Columbia University Irving Medical Center Recruiting New York New York 10032 United States Details
Memorial Sloan Kettering Cancer Center Recruiting New York New York 10065 United States Details
James Care Gynecologic Oncology at Mill Run Recruiting Hilliard Ohio 43026 United States Details
Stephenson Cancer Center Recruiting Oklahoma City Oklahoma 73104 United States Details
Sarah Cannon Research Institute Recruiting Nashville Tennessee 37203 United States Details
Peter MacCallum Cancer Center Recruiting Melbourne Victoria 3000 Australia Details
Universitair Ziekenhuis Antwerpen Recruiting Edegem Antwerp 2650 Belgium Details
Grand Hôpital de Charleroi Recruiting Charleroi Hainaut 6000 Belgium Details
UZLeuven Recruiting Leuven Vlaams Brabant 3000 Belgium Details
University College London Hospitals Recruiting London England NW1 2BU United Kingdom Details
The Christie NHS Foundation Trust Recruiting Manchester Greater Manchester M20 4BX United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field